Related Experiment Videos
Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis
1Department of Psychiatry, Veterans General Hospital-Taipei, Taiwan, ROC. sjtsai@vghtpe.gov.tw
Medical Hypotheses
|April 18, 2003
Summary
Brain-derived neurotrophic factor (BDNF) may be involved in attention-deficit hyperactivity disorder (ADHD). Treatments for ADHD increase BDNF, suggesting a role in both the disorder and its therapy.
Area of Science:
- Neuroscience
- Neurobiology
- Developmental Neuroscience
Background:
- Brain-derived neurotrophic factor (BDNF) is crucial for neuronal development and function.
- Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder impacting children, characterized by inattention and hyperactivity.
- Current ADHD treatments, including psychostimulants and antidepressants, have been observed to increase central BDNF levels.
Purpose of the Study:
- To propose a hypothesis on the potential role of BDNF in the pathogenesis of ADHD.
- To explore the possible involvement of BDNF in the therapeutic mechanisms of ADHD treatments.
Main Methods:
- This study is a hypothesis-driven review and theoretical proposal.
- It synthesizes existing literature on BDNF, ADHD, and common pharmacotherapies.
Main Results:
- Existing ADHD medications elevate BDNF levels in the central nervous system.
- This observation suggests a potential link between BDNF and ADHD pathophysiology.
Conclusions:
- BDNF may play a significant role in the development and progression of ADHD.
- Targeting BDNF could represent a novel therapeutic strategy for managing ADHD.
- Further research is warranted to elucidate the precise mechanisms linking BDNF to ADHD.